Straburzyńska-Migaj Ewa, Ochotny Romuald, Cieśliński Andrzej
1st Department, Poznan University of Medical Sciences, Poland.
Kardiol Pol. 2007 Apr;65(4):354-60; discussion 361-2.
There is increasing evidence for the importance of peripheral abnormalities in the pathogenesis and progression of heart failure (HF). Recently, glucose and insulin metabolism abnormalities have been intensively investigated in patients with HF.
To investigate whether coexistence of impaired glucose tolerance (IGT) may decrease exercise tolerance and influence ventilatory response to exercise in patients with systolic HF.
Maximal cardiopulmonary exercise test with evaluation of peak VO2 and VE/VCO2 slope and oral glucose tolerance test were performed in 64 clinically stable patients with HF and LVEF <45%.
Impaired glucose tolerance was diagnosed in 26 (41%) patients and normal glucose tolerance (NGT) in 38 (59%) patients. There were no significant differences in baseline clinical characteristics or LVEF between groups. There were significant differences in peak VO2 between IGT and NGT (15.4+/-4.1 vs. 18.7+/-4.2 ml/kg/min respectively; p=0.003) and VE/VCO2 slope (35.7+/-7.3 vs. 31.8+/-5.7 respectively; p=0.02). The IGT was independently related to peak VO2 and VE/VCO2 slope in multivariate regression analysis.
The IGT is associated with worse exercise capacity and ventilatory response to exercise in patients with HF.
越来越多的证据表明外周异常在心力衰竭(HF)的发病机制和进展中具有重要意义。最近,HF患者的葡萄糖和胰岛素代谢异常受到了深入研究。
探讨糖耐量受损(IGT)并存是否会降低收缩性HF患者的运动耐量并影响运动时的通气反应。
对64例临床稳定的HF患者且左心室射血分数(LVEF)<45%进行了最大心肺运动试验以评估峰值摄氧量(VO2)和通气当量(VE/VCO2)斜率,并进行了口服葡萄糖耐量试验。
26例(41%)患者被诊断为糖耐量受损,38例(59%)患者糖耐量正常(NGT)。两组间基线临床特征或LVEF无显著差异。IGT组和NGT组的峰值VO2(分别为15.4±4.1与18.7±4.2 ml/kg/min;p=0.003)和VE/VCO2斜率(分别为35.7±7.3与31.8±5.7;p=0.02)存在显著差异。在多因素回归分析中,IGT与峰值VO2和VE/VCO2斜率独立相关。
IGT与HF患者较差的运动能力和运动时的通气反应相关。